https://regulatorynews.com/jemperli-dostarlimab-rectal-cancer-practice-impact Regulatory News en 2026-10-21T10:51:44-04:00 FDA Approves First Immunotherapy for Rectal Cancer https://regulatorynews.com/tumorsight-risk-ai-breast-cancer-recurrence-practice-impact Regulatory News en 2026-10-21T10:51:44-04:00 FDA Clears AI Tool to Score Breast Cancer Recurrence https://regulatorynews.com/cytokinetics-myqorzo-health-canada-approval Regulatory News en 2026-10-21T09:43:16-04:00 Cytokinetics Expands MYQORZO Access to Canada https://regulatorynews.com/estuary-biotherapeutics-series-a-financing Regulatory News en 2026-10-21T09:43:16-04:00 Estuary Launches With $103M for Kidney Gene Therapy https://regulatorynews.com/gore-viabahn-vbx-fevar-bevar-approval Regulatory News en 2026-10-21T09:43:16-04:00 Gore Wins FDA Nod for First On-Label Bridging Stent https://regulatorynews.com/gsk-jemperli-rectal-cancer-accelerated-approval Regulatory News en 2026-10-21T05:58:10-04:00 FDA Approves GSK's Jemperli for Rectal Cancer https://regulatorynews.com/haemonetics-perqseal-elite-fda-approval Regulatory News en 2026-10-21T05:58:10-04:00 FDA Approves Haemonetics' PerQseal Elite Device https://regulatorynews.com/mhra-plozasiran-redemplo-authorisation Regulatory News en 2026-10-21T05:58:10-04:00 MHRA Authorises Redemplo for Rare Lipid Disorder https://regulatorynews.com/sensydia-cardiac-performance-system-financing Regulatory News en 2026-10-20T09:55:53-04:00 Sensydia Lands $6M to Push Heart Monitor to FDA https://regulatorynews.com/verastem-oncology-offering-vs-7375-phase3 Regulatory News en 2026-10-20T09:55:53-04:00 Verastem Raises $250M, Aligns FDA on Phase 3 https://regulatorynews.com/lilly-foundayo-orforglipron-chmp-opinion Regulatory News en 2026-10-20T05:53:25-04:00 CHMP Recommends Lilly's Oral GLP-1 Foundayo https://regulatorynews.com/sequel-twiist-type2-diabetes-clearance Regulatory News en 2026-10-20T05:53:25-04:00 FDA Clears Twiist Pump for Type 2 Diabetes https://regulatorynews.com/ucb-zilbrysq-autoinjector-approval Regulatory News en 2026-10-20T05:53:25-04:00 FDA Approves Autoinjector for UCB's Zilbrysq